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Aim: To evaluate if internet-delivered Cognitive Behavioral Therapy for insomnia (ICBT-i) with brief
therapist support outperforms an active control treatment.
Method: Adults diagnosed with insomnia were recruited via media (n ¼ 148) and randomized to either
eight weeks of ICBT-i or an active internet-based control treatment. Primary outcome was the insomnia
severity index (ISI) assessed before and after treatment, with follow-ups after 6 and 12 months. Sec-
ondary outcomes were use of sleep medication, sleep parameters (sleep diary), perceived stress, and a
screening of negative treatment effects. Hierarchical Linear Mixed Models were used for intent-to-treat
analyses and handling of missing data.
Results: ICBT-i was signiﬁcantly more effective than the control treatment in reducing ISI (Cohen's
d ¼ 0.85), sleep medication, sleep efﬁciency, sleep latency, and sleep quality at post-treatment. The
positive effects were sustained. However, after 12 months the difference was no longer signiﬁcant due to
a continuous decrease in ISI among controls, possibly due to their signiﬁcantly higher utilization of
insomnia relevant care after treatment. Forty-six negative effects were reported but did not differ be-
tween interventions.
Conclusions: Supported ICBT-i is more effective than an active control treatment in reducing insomnia
severity and treatment gains remain stable one year after treatment.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Insomnia means an inability to fall asleep, and/or waking up too
early in the morning or during the night, resulting in non-
restorative sleep and decreased day-time functioning (APA, 2013).
When using stringent diagnostic criteria the point prevalence of
insomnia in a general population is between 6% and 10% (Ford &
Kamerow, 1989; Morin & Jarrin, 2013). The burden of disease is
substantial, both for society (Daley, Morin, LeBlanc, Gregoire, &
Savard, 2009) and for the individual, who not only suffers from
the direct consequences of low quality sleep and worry about sleep,
but also from an increased risk of, for example, depression (Buyssel trial, at Clinicaltrials.gov as
6099.
Clinic, Karolinska University
Ltd. This is an open access article uet al., 2008; Ford & Kamerow, 1989) and hypertension (Suka,
Yoshida, & Sugimori, 2003).
Pharmacological treatment is effective but only recommended
for short term use. It may cause negative side-effects such as
disturbed sleep architecture, memory and psychomotor impair-
ment, rebound insomnia, and withdrawal effects (Wilson et al.,
2010). In comparison, although data on possible negative effects
of treatment are lacking, psychological treatment for insomnia in
the form of cognitive behavioral therapy (CBT) has strong evidence
(Riemann & Perlis, 2009) with sustained improvements. However,
treatment access is low since qualiﬁed CBT-therapists are rare
(Larsson, Kaldo, & Broberg, 2009) and expensive (van Straten &
Cuijpers, 2008).
Self-help treatments with minimal guidance from a therapist
could be one way to reduce the problems of availability and costs.
Historically, the effects of self-help books for insomnia have been
small to moderate and maintained at long-term follow-ups (van
Straten & Cuijpers, 2008). A more recent form of guided self-help,
internet-delivered Cognitive Behavioral Therapy with therapistnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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psychiatric conditions (Andrews, Cuijpers, Craske, McEvoy, & Titov,
2010; Hedman, Ljotsson, & Lindefors, 2012).
A number of studies have been conducted on internet-delivered
self-help for insomnia since the ﬁrst study in 2004 by Strom and
colleagues (Strom, Pettersson, & Andersson, 2004), which despite a
number of methodological problems showed promising results.
Several studies with no therapist support, or with automated
feedback only, have presented positive results (Lancee, van den
Bout, van Straten, & Spoormaker, 2012; Ritterband et al., 2009;
Ritterband et al., 2012), in one case also when compared to a
non-guided internet-based placebo condition (Espie et al., 2012).
However, a meta-analysis demonstrates that for a range of
conditions, therapist guided internet-treatments result in larger
effects than non-guided versions (Spek et al., 2007). When it comes
to ICBT for insomnia, the importance of therapist support is less
clear. Studies of ICBT-i with automated feedback only have shown
large effects (Ritterband et al., 2012; Espie et al., 2012). On the other
hand, it has been shown that minimal therapist guidance can make
a substantial difference when added to a self-help book (Jernelov
et al., 2012), with the additive effect of support mediatied by an
increased involvement in the most important therapeutic methods
(Kaldo, Ramer€o, & Jernel€ov, 2015). A recent study tested an ICBT
program including 15e30 min of active therapist support each
week (Van Straten et al., 2013). Effects were overall large, but the
diagnostics relied on cut-offs and the comparison was a pure wait-
list and not an active control treatment. Another study also showed
positive results for therapist-supported ICBT but were less gener-
alizable since it targeted patients with both insomnia and depres-
sion (Blom et al., 2015).
Many previous studies on ICBT-i are uninformative on the long
term effects since most studies had no or only short follow-ups
(2e14 weeks). One six months follow-up showed durable effects,
but the waitlist had then received the intervention and could no
longer serve as a control (Ritterband et al., 2009). The 48 week
follow-up in a study by Lancee et al. (2012), although positive, also
lacked an untreated control-group and showed attrition rates of
38%e65%.
Another general shortcoming of previous research is that even
though the importance of reducing sleep medications has been
stressed (Ritterband et al., 2009; Van Straten et al., 2013), previous
studies have seldom included use of sleep medication as an
outcome, and some studies that did measure it showed no decrease
(Espie et al., 2012; Van Straten et al., 2013).
In general, the reporting of negative treatment effects, or
adverse events, has been a neglected aspect of psychological
treatments so far (Barlow, 2010), and this is also true for both CBT
and ICBT. In face-to-face treatment it has been estimated that about
5e10% of all patients are afﬂicted by negative effects, and there has
recently been a call for regularly probing for these events also in
internet-based interventions (Rozental et al., 2014).
In summary, even though a number of studies generally show
positive effects for internet interventions for insomnia, there is still
a lack of knowledge on long term effects, how a therapist-guided
internet intervention compares to an active control treatment, ef-
fects on sleep medication use, and possible negative treatment
effects.
The aim of this study was to evaluate if therapist guided
internet-delivered CBT for insomnia (ICBT-i) was more effective
compared to an active internet-delivered control treatment (ICBT-
ctrl; not including the most efﬁcacious CBT-i-methods), in reducing
insomnia symptoms and improving sleep parameters directly after
treatment, after six months, and after a year. In addition, the
within-group long term stability of gains of ICBT and the effects on
sleep medication were evaluated. We also wanted to screen forpossible negative treatment effects, and to apply rigorous methods
for handling missing data.
2. Methods
This study was undertaken as a randomized controlled trial
comparing two active treatments and is reported in accordance
with the CONSORT statement for non-pharmacological trials
(Boutron, Moher, Altman, Schulz, & Ravaud, 2008). The study was
conducted at the Internet Psychiatry Clinic, part of the public health
care in the Stockholm County, Sweden. The study protocol was
approved by the regional ethics review board in Stockholm, Swe-
den (2009/1810-31/3). The trial was registered at Clinicaltrials.gov,
registration ID: NCT01256099.
2.1. Participants and recruitment
Participants were recruited via advertisements and articles in
daily newspapers, via a website for clinical trials in Sweden (www.
studie.nu), and via the public web site of the Internet Psychiatry
Clinic (www.internetpsykiatri.se). Individuals interested in partici-
pating signed informed consent and completed eighteen screening
questionnaires via the internet. The screening questionnaires
included the Insomnia Severity Index (ISI; Bastien, Vallieres,&Morin,
2001), a self-report version of the Montgomery Åsberg Depression
Rating Scale (MADRS-Svanborg & Asberg, 1994), Alcohol Use Disor-
ders Identiﬁcation Test (AUDIT; Saunders, 1993), the Drug Use Dis-
orders Identiﬁcation Test (DUDIT; Berman, Bergman, Palmstierna, &
Schlyter, 2005), questions on demographic data (e.g. age, gender,
education), practical pre-requisites for participating in the study, and
a checklist screening for sleep disorders, somatic disorders, behav-
ioral medicine conditions, and psychiatric conditions.
Inclusion criteria were:
a) 18 years or older,
b) Insomnia diagnosis according to the research criteria from
American Academy of Sleep Medicine (Edinger et al., 2004),
assessed in a structured diagnostic interview,
c) Insomnia at a clinical level deﬁned as more than 10 points on
ISI according to Morin (1993),
d) Ability to read and write in Swedish and no foreseeable
practical problems to participate in the study,
e) No comorbid sleep disorders primarily requiring other
treatment (e.g. sleep apnea or narcolepsy),
f) A consumption of alcohol/drugs deemed to not substantially
affect sleep or interfere with treatment,
g) Not started to use or changed the dose of antidepressant
drug during the last 2 months,
h) No somatic or psychiatric conditions requiring acute care or
being contraindicative of essential interventions in insomnia
treatment (e.g. bipolar disorder),
i) Not fulﬁlling the DSM-IV criteria for current Major Depres-
sion episode,
j) Not working night shifts.
Other comorbidities were allowed. Sleep medicine use was
unrestricted.
2.1.1. Initial screening
All criteria except (b), (g), and (i) where reviewed on basis of the
screening questionnaires. AUDIT-scores above 19 for men and
above 14 for women, and a DUDIT-score above 8 and 2 respectively,
were reviewedmore thoroughly and led to exclusion if addiction or
abusewas apparent (f). Scores above 30 on theMADRS-S total score
and above 3 on the item on suicidal ideation led to exclusion (h).
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All individuals who were not initially excluded went through a
structured and diagnostic telephone interview including: checking
diagnostic criteria for insomnia (b) and depression (i), socio-
demographic data, sleep difﬁculties, previous treatments (g),
motivation and ability to take part in the study, speciﬁc questions
on sleep related disorders, and a screening for a list of other psy-
chiatric and somatic disorders and rating each as ‘not present’, ‘less
probable’, and ‘probable’. Also, an interview-version of ISI was
administered as described below.
Individuals who fulﬁlled inclusion criteria and completed the
pre-treatment measures were included in the study and random-
ized. Table 1 presents the pre-treatment characteristics of all
included participants (n ¼ 148). Fig. 1 presents the ﬂow of partic-
ipants through recruitment, treatment and follow-ups.
2.2. Outcome measures
2.2.1. Primary outcome measure
2.2.1.1. Insomnia severity. The insomnia severity index (ISI; Bastien,
Vallieres, et al., 2001; Bastien, Vallieres, et al., 2001), with 7 items
rated from 0 to 4 on the severity of initial, middle and late
insomnia; sleep satisfaction; interference of insomniawith daytime
functioning; noticeability of sleep problems by others; and distress
about sleep difﬁculties. The psychometric properties of ISI are
adequate and it is sensitive to change (Bastien, Vallieres, et al.,
2001), also when web-based (Thorndike et al., 2011).
Since some level of missing data could be expected in this study,
especially on the web-based questionnaires (including ISI) at long
term follow-ups (Lancee et al., 2012), the recommendations by
Hedman et al. (2013) were followed by including an interview
version of the primary measure to be administered at all
assessment-points before and after treatment. This was based on
the ﬁrst ﬁve items in ISI, most closely covering the diagnostic
criteria. These questions and their response options were read to
the participants verbatim and the participant were asked to chooseTable 1
Pre-treatment characteristics of participants.
Characteristic ICBT n
No of women 59 (8
Age (sd) 47 (1
Level of Education
Elementary school 5 (7
High school 14 (1
University 54 (7
Married or partner 49 (6
Employment
Full or part time 58 (8
On sick leave or unemployed 6 (8
Retired or other 9 (1
Current economic status 1 (very poor) e 5 (very good) 3.6 (0
Years with sleep difﬁculties (sd) 10.8 (1
Average number of self-reported co-morbid conditions (sd)a
Probable 1.8 (1
Less probable 4.2 (2
Using one or more pharmacological and herbal remedies:
Sleep medications 33 (4
Pain medications 11 (1
Antidepressants 5 (7
Allergy medications 11 (1
Other medications 16 (2
Naturopathic (alert) 10 (1
Naturopathic (sleep) 7 (1
Naturopathic (other) 9 (1
Not using any drug 18 (2
Note. Signiﬁcance tests for continuous variables performed with t-test, otherwise Chi-2
a The probability of the participant actually having a diagnosis are estimated in the teone response option. The ﬁve-item version of ISI had a Cronbach's
alpha of 0.83. Based on a regression analysis using data from both
ISI and the interview version of ISI at the follow-ups (showing a
strong and signiﬁcant correlation of r ¼ 0.83), a formula to trans-
form interview-ISI values to ISI values were calculated to enable a
replacement of missing ISI data.
2.2.2. Secondary outcome measures
2.2.2.1. Sleep diary. A sleep diary was used for one week at all
assessment points. Each day, participants registered bed time, time
of falling asleep, night time awakenings, time of waking up and
time of getting out of bed. Also, subjective sleep quality was rated
daily on a 1 to 5 point scale fromvery poor to very good. From these
data sleep efﬁciency, sleep onset latency, total sleep time and sleep
quality were calculated.
2.2.2.2. Stress. To measure the level of subjective stress, the
Perceived Stress Scale 4 item version (PSS-4; Cohen, Kamarck, &
Mermelstein, 1983), was used. Each item has the response alter-
natives 0 (never) to 4 (very often) and total score range from 0 to 16.
2.2.2.3. Sleep medications. Data from self-ratings, interviews and
sleep diaries were cross-checked to determine the use of sleep
medications before and after treatment. At post-treatment, com-
plementary data on more speciﬁc changes in use of sleep medica-
tion during the treatment period were also collected.
2.2.3. Clinical signiﬁcance e responders and remitters
Calculation of treatment response and remission rates follows
previous recommendations (Morin et al., 2009): a responder was
deﬁned by a change in ISI score with 8 points or more compared to
pre-assessment and participants with an absolute ISI score less
than 8 were deﬁned as remitters.
2.2.4. Other measures
2.2.4.1. Negative effects. A screening for negative treatment effects¼ 73 ICBT-ctrl n ¼ 75 Statistics
1%) 57 (76%) n.s.
5.2) 49 (15.6) n.s.
%) 1 (1%) n.s.
9%) 18 (24%)
4%) 56 (75%)
7%) 53 (71%) n.s.
0%) 55 (73%) n.s.
%) 4 (6%)
2%) 16 (21%)
.81) 3.8 (0.98) n.s.
1.5) 10.2 (9.3) n.s.
.6) 1.9 (1.5) n.s.
.8) 4.2 (2.5)
5%) 37 (49%) n.s.
5%) 7 (9%) n.s.
%) 9 (12%) n.s.
5%) 14 (19%) n.s.
2%) 18 (24%) n.s.
4%) 2 (3%) p < .05
0%) 4 (5%) n.s.
2%) 9(12%) n.s.
5%) 23 (31%) n.s.
is used.
lephone interview and rated as Not present, Probable or Less probable.
Fig. 1. Participant ﬂow-chart (CONSORT). ICBT-i ¼ Treatment; ICBT-ctrl ¼ Control treatment.
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treatment. The interviewers asked all participants the question
“Did the treatment lead to any negative consequences?”. If yes, they
were asked to describe these consequences, and if the answer was
unclear the interviewer asked the participant to be more speciﬁc.
When all data had been collected, the answers from all threeoccasions were combined and grouped according to their thematic
content.
2.2.4.2. Treatment satisfaction. The Client Satisfaction Question-
naire, (CSQ-8; Attkisson & Zwick, 1982) measured overall patient
satisfaction at the end of each treatment. Each item is rated from 1
V. Kaldo et al. / Behaviour Research and Therapy 71 (2015) 90e10094to 4 and the total score ranges from 8 (low satisfaction) to 32 (high
satisfaction). Internal consistency of the CSQ-8 has been reported to
be high (Cronbach's alpha ¼ 0.93).
2.2.4.3. Therapist contact. Therapist time was only measured for
ICBT-i since the control treatment did not receive therapist guid-
ance. The time therapists spent on reviewing and giving feedback
to homework reports and sleep diaries, reading and writing an-
swers to questions the participants had, and reminding inactive
participants via messages and SMSwas logged, as was the numbers
of messages the participant sent to the therapist and vice versa.
2.2.4.4. Participant adherence. In the ICBT-i group, the number of
activated modules and the number of homework reports was log-
ged. To capture the overall engagement in each of the two in-
terventions, all participants were asked at post-treatment how
much of the self-help text they had read (with the options none,
25%, 50% 75%, and 100%) and how many hours a week they had
spent working with the treatment methods.
2.3. Randomization and assessment points
This study was a randomized controlled trial with two arms
(ICBT-i and ICBT-ctrl). The participants were randomized by people
not involved in the study, using www.random.org as a true random
number source and randomization clusters of different sizes. All
outcome measures were assessed before and after treatment, and
at 6 and 12 months after treatment.
Assessors and therapists were not blind to treatment condition.
2.4. Interventions
2.4.1. General description
Both treatments lasted eight weeks and consisted of eight
modules, accessed on a secureweb site. They were also similar on a
range of other features: a module consisted of a text to read, control
questions on the treatment and the theory behind it, behavioral
assignments, sleep diary registrations and work sheets; the par-
ticipants were expected to complete one module per week; par-
ticipants had access to a discussion forum including the other
participants in the same study arm; ISI and MADRS-S were ﬁlled
out on a weekly basis and the therapist had access to this data
which allowed monitoring of the participant's progress and alerted
the responsible clinician if a participant scored 4 or more points on
the suicidal ideation item in MADRS-S (item 9).
2.4.2. Insomnia treatment (ICBT-i)
The basis for the ICBT-i treatment was well-established CBT
techniques for insomnia, with sleep restriction and stimulus con-
trol as the two most important methods (Harvey, Inglis, & Espie,
2002; Morin et al., 2006). The treatment content was delivered
both online and in a book (Jernelov, 2008) that had been previously
shown to produce large effects on insomnia symptoms (Jernelov
et al., 2012). The printed material was divided into several mod-
ules (i.e., chapters) that included psychoeducative text and each
module was accompanied by online material that consisted of
reading instructions, a brief summary, sleep diary, weekly assign-
ments, work sheets, weekly symptoms measures, homework re-
ports and written communication with the therapist. The sleep
diary and all worksheets existed both as printer friendly pdf-ﬁles
and in digital forms that were ﬁlled out by the patients when
reporting homework in the treatment platform. The modules in
ICBT-i were: Introduction and facts about sleep; CBT for insomnia
and sleep hygiene; education on sleep medication and tapering
(given only to patients with sleep medication); sleep restrictionand stimulus control; stress management; managing fatigue;
handling negative thoughts about sleep; planning ahead.
The ﬁrst, the second and the last modules were ﬁxed, but the
order of the remaining modules was determined by the therapist
and participant together based on data from the pre-treatment
assessment and the results of an interactive treatment guide ﬁl-
led out by the patient at the start of the treatment. Sleep restriction
and stimulus control were never omitted from the treatment plan.
The basic instructions for sleep restriction was to ﬁrst calculate
average time slept each night during one week to constitute the
initial allowed time in bed (with nominimum time set beforehand).
When weekly average sleep efﬁciency reached over 85%, the sleep
windowwas increased by 15min, but if it went below 80% the sleep
window was decreased by 15 min.
Each module ended with a home-work report which the patient
ﬁlled out and sent to their therapist. The therapist reviewed the
home-work report, the sleep diary data, work sheets, and weekly
insomnia and depression ratings. Written feedback was given
within 48 h and the therapist then gave the participant access to
the next module. Also, if the participant was inactive for 7 days, the
system alerted the therapist to send a mobile phone text message
(SMS) as a reminder and encouragement. If needed, another SMS
was sent, followed by an e-mail and then by telephone calls.
Therapists in the present study (n¼ 8) were in their ﬁnal year of
the Swedish 5-year university program for clinical psychologists
and had training in CBT for at least 18 months. They all received a
one-day course in CBT for insomnia and were supervised weekly by
a licensed clinical psychologist with expertise in CBT for insomnia
(KB).
2.4.3. Active control treatment (ICBT-ctrl)
The control treatment was designed to be an active intervention
to control for the more general positive effects of participating in a
treatment. To make ICBT-ctrl credible it was decided to incorporate
some components with previously established speciﬁc effects on
insomnia, but three strategies were used to make these less likely
to be as effective as the ICBT-i program. First, the control treatment
only included components with less empirical support and often
low effects; sleep hygiene (Alexandru, Robert, Viorel, & Vasile,
2009), relaxation (Alexandru et al., 2009; Lichstein, Riedel,
Wilson, Lester, & Aguillard, 2001), and mindfulness (Ong, Shapiro,
& Manber, 2008), complemented with general stress manage-
ment. Sleep restriction and stimulus control or other advice on how
to more directly affect the sleep pattern were thus not included.
Second, these methods were presented in a rather short and
compact format and the exercises given to the patients were less
frequent and intensive than usually recommended to reach full
effect. For example, in relaxation only quick relaxation was used
and mindfulness was only presented as one short exercise without
clear-guidelines on how often to relax and in neither case the use of
continuous registrations was encouraged. Third, no therapist
guidance was given in ICBT-ctrl in order to not provide the partic-
ipants with expertise feedback on their homework or suggestions
onmethods not included in the program. Only support on technical
questions and issues where given on demand, and an SMS was sent
as a reminder at the start of treatment and when module two was
activated.
In short, the control treatment included well-known CBT com-
ponents to increase credibility and avoid nocebo-effects, but did
not include the components considered the most effective for
insomnia treatment, and also no therapist support.
The modules of the ICBT-ctrl were: psychoeducation on sleep,
psycheducation on insomnia and setting treatment goals, sleep
hygiene I (light, sound, temperature), sleep hygiene II (exercise,
food, alcohol/nicotine/caffeine), applied relaxation, stress
V. Kaldo et al. / Behaviour Research and Therapy 71 (2015) 90e100 95management, mindfulness, and treatment evaluation and mainte-
nance. The treatment module for the upcoming week was opened
each Sunday. Participants could work with the module material
online, and were also encouraged to print out each module and the
included registration sheets. At the end of each module, a home-
work report checklist was used by the participants to review
their own homework. Also, in each weekly questionnaire, together
with the ratings of insomnia and depression, participants reported
which methods they had used and reﬂected on how these had
worked out. Daily registrations in a sleep diary were recommended,
as well as using these to explore patterns and factors that affected
sleep. Participants were also encouraged to write comments in the
discussion forum and for each module submit a post on a speciﬁc
theme.
2.4.4. Treatment adherence
The self-help material assures a highly standardized way to
deliver treatment. The self-help manual accounted for a major part
of the therapeutic information the participants received during
treatment, minimizing individual therapist inﬂuence. Furthermore,
adherence to the treatment protocol in the group with guidance
was ascertained through the use of a therapist manual and
supervision.
2.5. Statistics
2.5.1. Analyzing outcome e linear mixed model
Hierarchical linear mixed effect modeling was used to perform
signiﬁcance tests for continuous outcome data. Mixed-effects
models have several advantages compared to traditional statisti-
cal methods, in particular its superior ability to handle missing data
(Gueorguieva & Krystal, 2004) and the inclusion of person-speciﬁc
intercepts and change parameters (i.e., random effects) in the
model. We used linear mixed models to examine the difference in
rates of change between ICBT-i and ICBT-ctrl over the four assess-
ment points. We did not expect the rates of change to be constant
from pre-treatment to 12-months follow-up, but that the most
pronounced changeswould occur during treatment and any change
after the post-treatment assessment would occur at slower pace.
Initial visual inspection conﬁrmed these expectations.We therefore
ﬁt the data to a basic model consisting of a two-part piecewise
function. The ﬁrst function, or piece, described a linear change from
pre-to post-treatment and the second piece described a linear
change from post-treatment to the follow-ups at 6 and 12 months.
Full information maximum likelihood estimationwas used to ﬁt
the model. The strategy to ﬁnd the best model for each outcome
variable was to start with the basic model with group (coded as
0 for the ICBT-i group and 1 for the ICBT-ctrl group), time1 (for piece
1), time2 (for piece 2), group  time1, and group  time2 as ﬁxed
effects. Then random intercepts, random effects of time1 and
time2, and a repeated measures effect were sequentially added and
retained if they improved the model ﬁt according to log-likelihood
ratio tests for nested models.
Hypothesis-testing was then based on the estimates of the
following effects obtained in the models: A signiﬁcant interaction
effect of time1 and group indicated difference in symptom reduc-
tion between the groups during treatment. A signiﬁcant interaction
effect of group and time2 indicated difference in durability of im-
provements gained during treatment. To test the group difference
at each long-term follow-up assessment, the time variables were
adjusted to move the intercept to each of these measurements
points and then the effect of group (at the relocated intercept) were
tested. The models also allowed for interpretation of the main (or
simple) effects of time as tests of signiﬁcant within-group effects
for the two groups during the two time-periods, i.e. change frompre-treatment to post-treatment and from post-treatment to 12
months follow-up within each group. To obtain these effects for the
ICBT-i group, the groups were recoded to 0 for the ICBT-ctrl and 1
for the ICBT-i group.
2.5.2. Missing data analysis
The modeling approach utilized all available data from all par-
ticipants and measurement points, which made this an intent-to-
treat analysis. Full information maximum likelihood estimation
provides unbiased parameter estimates in the presence of missing
data under the assumption of data missing at random (MAR) and
outperforms traditional methods (e.g., last observation carried for-
ward) in most missing data situations (Lane, 2008; Mallinckrodt,
Clark, & David, 2001). The MAR assumption requires that all known
correlates of datamissingness (i.e. towhat degree data ismissing) are
included in the analysis.We therefore performed sensitivity analyses
where a number of covariates were added to the model for each
outcome measure. All pre-treatment characteristics that correlated
with either outcome or missingness and also signiﬁcantly improved
the model ﬁt were included. Sensitivity analyses that deviated from
the primary analyses are reported in the Results section.
Since more participants had completed the telephone-
administered version of ISI than the internet-administered
version, this measure was used to make a speciﬁc test of the rela-
tion between missingness and outcome.
2.5.3. Other statistical analyses and power
When deciding responder and remitter status, participants with
missing data had their status carried forward from the last obser-
vation, and thus participants with only pre-treatment data avail-
able were deﬁned as non-responders and non-remitters at all
measurement points. Chi-2 tests, t-tests and Pearson's r were also
used to analyze observed data where appropriate. The original
power calculations were made on an estimated difference of 0.6
(Cohen's d) at post-treatment, with which an ordinary t-test would
need 60 participants in each group to render a power of 90%. The
use of mixed-effects models was not deemed to result in lower
power than a t-test and thus the current sample sizewere judged to
be satisfactory.
3. Results
3.1. Missing data and covariates included in the sensitivity analyses
The CONSORT ﬂowchart (Fig. 1) provides information on the
attrition at different measurement points.
The following pre-treatment characteristics were found to be
correlated to data missingness and were thus candidates for in-
clusion in the sensitivity analyses: Use of antidepressants, use of
naturopathics to improve sleep, and screening positive for Restless
Legs Syndrome or Delayed Sleep Phase Syndrome. In addition, the
pre-treatment variables that correlated with change in each spe-
ciﬁc outcome measure were candidates for inclusion in the sensi-
tivity analysis for the respective measure.
We explored whether there was a relationship between
interview-ISI scores and data missingness. At post-treatment and
6-month follow-up the effect of missingness was non-signiﬁcant
(t(124) ¼ 0.157; p ¼ .88 and t(123) ¼ 0.123; p ¼ .22), but after 12
months the telephone data revealed a signiﬁcantly (t(127) ¼ 2.31;
p ¼ .023) higher level of insomnia symptoms for participants with
missing data (n ¼ 23; m ¼ 8.5; SD ¼ 3.0) compared to those having
ﬁlled out the questionnaires (n ¼ 106; m ¼ 6.7; SD ¼ 3.4). We
therefore used interview-ISI data to impute missing data in ISI and
also included interview-ISI as a possible candidate in the sensitivity
analyses for the other measures.
Fig. 2. Insomnia severity during the 60-week trial period shown as observed (Obs.)
data and estimated (Est.) values resulting from the linear mixed models analysis used
for signiﬁcance testing. ICBT-i ¼ Treatment; ICBT-ctrl ¼ Control treatment.
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time
The ICBT-i treatment consisted of a total of 8 modules, but the
module on sleep medication was only opened to patients with
sleepmedications. An average of 6.8 (SD¼ 1.7) modules were made
available and the participants completed the homework report for
5.4 (SD ¼ 2.4) modules. The homework report of the most impor-
tant module on sleep restriction and stimulus control were ﬁlled
out by 60 of the 73 participants (82%).
Since the participants in ICBT-ctrl automatically gained access to
a new module each week, and no homework report or therapist
contact was included, adherence measured as number of modules
or homework reports could not be estimated for this group. How-
ever, on the question on howmuch of the treatment text they read,
ICBT-i read on average 84.2% (SD ¼ 19.6%) and ICBT-ctrl read 87.3%
(SD ¼ 19.9%) which did not differ signiﬁcantly (t(122) ¼ 0.86;
p ¼ .39). The self-reported number of hours spent on treatment
each weak was signiﬁcantly higher for the ICBT-i (M ¼ 6.1;
SD ¼ 4.5) compared to ICBT-ctrl (M ¼ 4.4; SD ¼ 4.1; t(122) ¼ 2.20M
p ¼ .03).
At the post-treatment measurement, the treatment satisfaction
measured with the CSQ-8 was signiﬁcantly lower for the control
treatment (M ¼ 18.7; SD ¼ 5.3) than for the insomnia treatment
(M ¼ 27.3; SD ¼ 4.5; t(122) ¼ 9.63, p < .001).
The therapists spent on average 1.91 h (SD ¼ 1.00; CI-95%¼ 1.67
to 2.14) in total on each patient in the ICBT-i condition. The number
of messages sent by the therapists was on average 17.7 (SD ¼ 6.4)
and the participants sent on average 18.7 (SD ¼ 10.5) messaged
(including homework reports). Telephone contact was utilized only
very few times to reach inactive participants that had neither
responded to written messages in the treatment platform, nor to
SMS. These telephone calls were not therapeutic in nature andwere
not registered.
3.3. Primary outcome e insomnia severity
The piecewise model that best ﬁt the data for ISI included two
random effects; the intercept and the slope of the ﬁrst piece be-
tween pre-treatment and post-treatment. Fig. 2 shows both the
observed means and the means estimated by the model.
The differences between the observed means and the estimated
means are due to the model's correction for missing data in the
latter and the fact that the second estimated time-piece describes
the overall linear trend from post-treatment to 1-year follow-up. As
more thoroughly presented in Table 2, ICBT-i produced a signiﬁ-
cantly greater reduction in ISI compared to ICBT-ctrl during treat-
ment, and after 6 month the participants in ICBT-i still experienced
a signiﬁcantly lower level of insomnia. However, after treatment
the two groups converged signiﬁcantly and at the 12-month
follow-up the difference was no longer signiﬁcant. This was
mainly due to continued improvement in ICBT-ctrl, since no sig-
niﬁcant deterioration was found for ICBT-i.
Large to very large within groups effect sizes were observed in
both groups at post, FU6 and FU12: Cohen's d (CI-95%) for ICBT-i
were 2.07 (1.66e2.46), 1.71 (1.33e2.08), and 1.95 (1.54e2.33) for
each respective time-point, and the corresponding effects for ICBT-
ctrl were 1.09 (0.75e1.43), 1.22 (0.87e1.56), and 1.50 (1.13e1.86)
respectively.
3.4. Clinical signiﬁcance e responders and remitters
The results are presented in Table 3. The general ﬁndings in the
continuous outcome variable were replicated for the categorical
data of responders and remitters, with signiﬁcant group differencesat post and 6-month follow-up but not after 12 months. The pro-
portion of responders in ICBT-i did not differ much between the
three measurement points after treatment (45%e52%), which was
also the case for remitters (37%e47%). This conﬁrms that the effects
were stable.
3.5. Secondary outcomes and sensitivity analyses
Table 2 presents the observed means and standard deviations
for ISI and secondary outcomes together with the estimated means
and effect sizes based on estimated data. Table 2 also presents the
results of the linear mixed models signiﬁcance tests for interaction
(time  group) within each time-piece and direct comparisons of
the groups at both follow-ups.
The most common patternwas the same as can be seen for ISI in
Fig. 2; ICBT-i was superior to ICBT-ctrl at post and 6-months follow-
up but after 12 months the ICBT-ctrl participants had experience
decrease in their symptoms to such extent that no signiﬁcant dif-
ferences were observed. The only exceptions were for sleep latency,
where ICBT-ctrl remained inferior to ICBT-i also after one year, and
for sleep time and stress (PSS-4) that did not differ at any time-point.
The sensitivity analyses, where all pre-treatment covariates that
correlated with either missingness or outcome (or both) and also
contributed signiﬁcantly to the model according to log-likelihood
ratio tests where added, did not change the results of the signiﬁ-
cance tests except in one case; Sleep Quality 6 months after treat-
ment. Here the sensitivity test indicated a type II error, since the
sensitivity analysis showed that ICBT-i was signiﬁcantly superior to
ICBT-ctrl when covariates were included in the model to correct for
the effects of missingness.
In addition to the analyses presented inTable 2, the effects of time
for the ICBT-i group were tested. All measures, except for the PSS-4
(p ¼ .077), indicated signiﬁcant improvement during the ﬁrst time-
piece (pre-post). Sleep time was thus signiﬁcantly increased for the
ICBT-i, even though no difference from the control treatment was
found, as reported above. There were no signiﬁcant effects during
the second time-piece (post e FU12), indicating that no further
improvementordeterioration for theparticipants in ICBT-i occurred.
3.6. Sleep medication and other treatments
During the year after treatment, 35 out of 68 (52%) of the par-
ticipants in the control group had utilized sleep medications or
Table 2
Primary and secondary outcomes and effect sizes.
Treatment ICBT-i Control treatment ICBT-ctrl Between groups effect sizes est. (CI-95)a Linear mixed models
M M est. SD M M est. SD Effect P
ISI (0e28)
Pre 16.8 16.8 3.8 16.5 16.5 3.8 Initial diff in change <0.001
Post 8.3 8.6 4.1 11.8 12.0 4.4 0.85 (0.51e1.18) Follow-up diff in change 0.002
FU6 9.5 8.8 5.4 11.5 11.0 5.1 0.55 (0.22e0.88) FU6 group diff <0.001
FU12 8.9 9.1 4.1 9.6 10.0 4.8 0.23 (0.1 to 0.55) FU12 group diff 0.26
Sleep efﬁciency (%)
Pre 70.6 70.6 11.9 71.5 71.5 9.9 Initial diff in change <0.001
Post 84.7 84.0 9.4 77.8 77.8 10.9 0.59 (0.26e0.92) Follow-up diff in change 0.01
FU6 83.2 83.3 9.5 79.6 79.6 8.8 0.40 (0.08e0.73) FU6 group diff 0.013
FU12 82.6 82.5 10.6 81.0 81.4 7.7 0.12 (0.2 to 0.44) FU12 group diff 0.43
Sleep Latency (min)
Pre 57.1 56.9 43.9 50.5 50.5 31.9 Initial diff in change 0.006
Post 27.4 29.1 24.8 40.4 39.3 32.1 0.35 (0.03e0.67) Follow-up diff in change 0.94
FU6 35.2 29.3 26.9 38.8 39.8 28.3 0.40 (0.07e0.72) FU6 group diff 0.008
FU12 27.7 29.6 17.2 41.2 40.3 27.1 0.49 (0.16e0.82) FU12 group diff 0.013
Sleep Time (h)
Pre 5.85 5.85 1.00 5.92 5.92 0.95 Initial diff in change 0.62
Post 6.61 6.61 0.96 6.50 6.58 1.08 0.03 (0.29 to 0.35) Follow-up diff in change 0.32
FU6 6.78 6.65 1.01 6.87 6.72 0.96 0.07 (0.39 to 0.25) FU6 group diff 0.62
FU12 6.58 6.69 0.95 6.73 6.86 0.85 0.17 (0.5 to 0.15) FU12 group diff 0.34
Sleep Quality (0e4)
Pre 2.74 2.74 0.59 2.75 2.75 0.57 Initial diff in change 0.022
Post 3.30 3.22 0.86 2.91 2.85 0.84 0.45 (0.12e0.77) Follow-up diff in change 0.070
FU6 3.12 3.17 0.90 2.84 2.97 0.98 0.25 (0.08 to 0.57) FU6 group diff 0.055/.021b
FU12 3.16 3.12 0.74 3.13 3.08 0.66 0.06 (0.26 to 0.39) FU12 group diff 0.81
PSS-4 (0e16)
Pre 5.8 5.8 3.1 5.5 5.5 3.3 Initial diff in change 0.97
Post 5.0 5.1 3.3 4.6 4.8 3.0 0.10 (0.42 to 0.22) Follow-up diff in change 0.60
FU6 5.2 4.9 3.6 5.0 4.8 3.4 0.03 (0.36 to 0.29) FU6 group diff 0.76
FU12 4.5 4.8 3.5 4.4 4.8 2.7 0.00 (0.32 to 0.32) FU12 group diff 0.98
Note. All statistical tests are performed on estimated values.
M Est¼ Estimated mean (in italics). ISI¼ Insomnia Severity Index (missing data imputed from the interview version of ISI when applicable). PSS-4¼ Perceived Stress Scalee 4
item version.
Initial diff in change denotes the interaction between time and group during piece 1 (pre-post). Follow-up diff in change denotes the interaction of time and group during piece
2 (post-FU12). FU6 group diff and FU12 group diff denotes the difference between groups at FU6 and FU12 respectively.
a Between group effect sizes as Cohen's D based on estimated m and SD (pooled).
b Group difference becomes signiﬁcant in the sensitivity analysis when covariates are added to the model.
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(including open market self-help information) to sleep better. In
comparison, the corresponding ﬁgures for the treatment group
were 22 out of 69 (32%), which was signiﬁcantly lower (Chi-
2(1) ¼ 5.4; p < .02).
More detailed sub-analyses revealed the following. Directly af-
ter treatment, 10% of patients (7 out of 68) in the treatment group
used sleep medication, which was signiﬁcantly fewer than in the
control treatment where 38% (25/65) used sleep medication (Chi-
2(1) ¼ 14.3; p < .001). A more detailed comparison of changes in
sleep medications from pre to post revealed that the treatment
group had a signiﬁcantly more favorable outcome (Chi-2(4) ¼ 15.4;
p¼ .004) with 24 patients having stopped, 6 patients decreased the
dose or frequency and none having started or increased. In the
control treatment, 8 patients had stopped and 6 had decreased, butTable 3
Responders and remitters in each group.
Post FU6
ICBT-i N (%) ICBT-ctrl N (%) ICBT-i N
Responders 37 (51%) 18 (24%) 33 (45%
Non-responders 36 57 40
Statistics Chi-2(1) ¼ 11.3; p ¼ .001 Chi-2(1
Remitters 31 (43%) 11 (15%) 27 (37%
Non-remitters 42 64 46
Statistics Chi-2(1) ¼ 14.1; p < .001 Chi-2(1
Note. Responder ¼ change in ISI >7. Remitter ¼ ISI<8. Missing data replaced according t5 had increased and 2 had started using sleep medications. At six
month follow-up 21% (14/67) of patients in the treatment group,
compared to 40% (26/65) in the control treatment were using sleep
medication, which was still a signiﬁcant difference (Chi-2(1) ¼ 5.7;
p ¼ .017). However, the increase in sleep medication in the treat-
ment group continued and reached 27% (18/66) after one year
which did not differ signiﬁcantly from the 37% (23/63) in the
control treatment (Chi-2(1) ¼ 1.3; p ¼ .17). Still, compared to pre-
treatment levels, the ICBT-i showed signiﬁcant decreases in sleep
mediations at both follow-ups (Chi-2(1) ¼ 8.2e4.1:
p ¼ .004e0.044) whereas this was not the case for ICBT-ctrl.
In addition to sleep medications, 14 out of 68 (21%) participants
in the control treatment, reported having initiated one ormore new
treatments or new strategies in their every-day life to sleep better
during the year after the treatment. This is proportionally moreFU12
(%) ICBT-ctrl N (%) ICBT-i N (%) ICBT-ctrl N (%)
) 20 (27%) 38 (52%) 31 (41%)
55 35 44
) ¼ 5.5; p ¼ .019 Chi-2(1) ¼ 1.7; p ¼ .19
) 16(21%) 34 (47%) 29 (39%)
59 39 46
) ¼ 4.4; p ¼ .036 Chi-2(1) ¼ 0.9; p ¼ .33
o the last observation carried forward principle.
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(Chi-2(1) ¼ 2.1; p ¼ .15).
3.7. Negative effects
In ICBT-i 15 patients reported one negative effect and four pa-
tients reported two. For the control treatment the corresponding
ﬁgures were 11 and 6. The total number of negative effects reported
did not differ between the treatments (t(34) ¼ 0.94; p ¼ .36).
Table 4 provides an overview of the themes of reported negative
experiences.
4. Discussion
This study shows that therapist-guided ICBT for insomnia was
superior to an active but unguided control treatment immediately
after treatment and six months afterwards, and resulted in a stable
reduction of insomnia symptoms also after one year. The primary
outcome measure, self-rated insomnia severity, was signiﬁcantly
reduced for ICBT-i compared to the control group and the im-
provements remained stable during the ﬁrst year after treatment.
The effect of ICBT-i was very large and signiﬁcantly larger than the
effect for the active control treatment immediately afterwards and
after six months. During the follow-up period, the control group
showed increasingly lower symptoms and at the 12-months
follow-up the difference between the two groups was no longer
signiﬁcant.
The positive effects of the treatment were also mirrored in the
sleep diary measures; sleep latency was more than halved to
29.7 min, sleep time increased with 45.6 min and sleep efﬁciency
was improved from 70.6% to 84.7%, all together being similar to
previous studies (Espie et al., 2012; Lancee et al., 2012; Ritterband
et al., 2009; Van Straten et al., 2013). Sleep latency was the only
parameter where ICBT-i was still superior over the control treat-
ment after one year, while the participants in ICBT-i did not sleep
longer than controls at any time-point. The latter is not surprising
since CBT for insomnia in general does not show very strong effects
on total sleep time but rather on sleep efﬁciency and quality. It was
rather more unexpected to ﬁnd the relatively large within group
increase in sleep time for participants in ICBT-i. This might have
been due to a rather long treatment period, where the most acute
effects of the application of sleep restriction (i.e. shorter sleep time)
hadworn off already at the time the post-treatment sleep diary was
ﬁlled in. It could also be related to the psychoeducation about sleep
that informed about light sleep which may feel like “you weren't
sleeping”, or the fact that participants in both groups may have
changed their way of recording their sleep in the sleep diary in
some systematic way during the intervention (i.e. a training effect).
Another important ﬁnding in this study was that ICBT-i can have
a positive effect in reducing sleep medication use, which has been
not been extensively studied previously. One explanation for our
ﬁnding might be that there is one (optional) module that focuses
solely on tapering. The ﬁndings in this study replicate the results ofTable 4
Types and number of negative effects reported at post, 6-month, and 1-year follow-up.
Themes of self-reported negative effects
The use of the sleep diary caused increased stress, worry and focus on sleep difﬁcultie
The technical platform or the treatment were perceived as being complicated and/or s
Disappointed in not better during treatment, increased hopelessness
Sleep restriction, or the use of the sleep diary in the control intervention, induced less
Stricter bedtimes use in sleep restriction resulted in unwanted change of habits or per
Sleep restriction gave extra time out of bed which was spent on eating, resulting in a
Sleep restriction induced less sleep and lower concentration resulting in a mistake at
Previous panic attacks returned when using sleep restrictionthe study by Jernelov et al. (2012) originally evaluating the self-help
manual used.
Unlike many studies on psychological treatments, not only for
insomnia, this trial included screening for negative effects during
and after the treatment. Fairly many negative effects were reported
but no overall difference between the interventions was found and
none of the self-reported events could be deﬁned as severe. When
analyzing the self-reported negative effects of treatment, it is
interesting to ﬁnd that individuals using the sleep diary in the
control treatment, which did not include very speciﬁc instructions
on how to analyze it, found it rather more stressful than those using
the sleep diary to do sleep restriction and stimulus control in the
active treatment. On the other hand, nine participants receiving the
active treatment indicated negative effects that were subjectively
related to sleep restriction, including rather unexpected effects
such as reduced freedom, weight gain and re-occurrence of panic-
attacks. However, none of these patients spontaneously reported a
markedly increased day-time fatigue and only three of them
mentioned less sleep or lower sleep quality. These are rather low
ﬁgures considering ﬁndings by Kyle et al. (2014) where more
objective and systematic measures of these factors showed clear
deterioration during sleep restriction. These ﬁndings should be
explored further in future research in line with the recommenda-
tions of Rozental et al. (2014).
To our knowledge, this is the ﬁrst study to compare ICBT-i to an
active control treatment for insomnia. The participants' adherence
to each intervention was similar in the proportion of self-help
material being read. Participants in ICBT-i spent more time on
working with the treatment methods, but participants in the con-
trol treatment still reported a fairly high degree of treatment
engagement with about an average of 35 min a day. The active
control treatment also performed rather well at post-treatment,
which is not so surprising since it included some credible and
effective methods such as sleep hygiene, relaxation, mindfulness,
and keeping a sleep diary (Alexandru et al., 2009; Lichstein et al.,
2001; Ong et al., 2008). But the control treatment also improved
signiﬁcantly more than ICBT-i after the post-treatment assessment.
This may be due to a combination of spontaneous recovery, a
delayed effect of treatment since all participants had access the
treatment material during six months after post-treatment mea-
sures, and the observed higher utilization of additional treatments
for insomnia during the follow-up period.
There are some limitations to this study. First, no untreated
control group was used. However, previous studies reviewed in the
introduction have shown that the absolutemajority of within group
effects of wait-lists lie below a Cohen's d of 0.50 which is markedly
lower even than the control treatment in this study. Second, no
complete blinding was used since participants in the control
treatment did receive information that they were allocated to a
condensed version of the full treatment and would not receive
support. This procedure was used in order to minimize possible
nocebo effects, that could occur if participants were to perceive the
intervention received as inferior to an expected treatment. ToICBT-i ICBT-ctrl
s 4 12
tressful 8 6
2 2
sleep or lower quality of sleep when applied 3 3
ception of a reduced freedom during the day 3 0
weight gain 1 0
work, although rather benign. 1 0
1 0
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tion of the treatment was done to make it equally effective but less
effortful. According to adherence estimations, control participants
took an active part in their treatment, and the comparatively large
effects, also relative to wait-lists in previous studies, indicate that
placebo- and/or speciﬁc effects of the semi-effective methods used
were larger than possible nocebo effects. However, nocebo effects
can still not be ruled out. Since the outcomes were based on self-
reports, the effects of non-blind assessors should be minimal.
Third, although the overall attrition rates were low, sleep diary
showed 30%e45% missing data. Even though state-of-the art
methods for handling missing data were used, the results from
sleep diary data should be interpreted with some caution.
Finally, the study was not designed to evaluate the speciﬁc effect
of therapist support, and hence no conclusion regarding such ef-
fects can be drawn. The control treatment lacked both therapist
support and some of the most effective techniques. However, it is
interesting to compare the effects in this study to the previous
study by Jernelov et al. (2012) where the same self-help manual
delivered as a book together with telephone support showed a
somewhat larger effect than that found in the present study on
insomnia severity (d ¼ 2.46 compared to d ¼ 2.07) and sleep pa-
rameters. This might indicate that highly structured phone calls on
a set time each week are better not only than no support at all, but
also than therapist contact through text messages via the internet.
However, since a number of previous trials have utilized automated
feedback rather than therapist support and received large effects
(Ritterband et al., 2012; Espie et al., 2012), it is still not clear if
therapist support is needed in ICBT for insomnia even though this
seems to be the case for ICBT in general (Spek et al., 2007).
In conclusion, in this study ICBT for insomnia including brief
therapist support is more effective in reducing insomnia severity
than an active control treatment, and treatment gains remain one
year after treatment. Together with previous studies, it strengthens
the evidence for this kind of intervention and calls for an increased
focus on implementation.
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